Express Next Day Delivery

The Medicines and Healthcare products Regulatory Agency (MHRA) called for a temporary halt on all home antibody tests on May 27th. All people who had taken the test were told to consider the results as unreliable. Before we get into the reason for this, we’ll explain how the home antibody tests work.


‍How does the coronavirus antibody test work?

‍An antibody test can detect if someone had coronavirus before and if they’re fully recovered from it. A positive result means that a person has had coronavirus in the past, while a negative result indicates that they’ve never had it.

If you use a home test you prick your finger and collect some of your blood, this blood sample will then be sent to a lab. The lab will test your blood for antibodies to SARS-CoV-2, which is the virus that causes COVID-19.

There are two types of antibodies and the test will look for either of them. First there is the IgM antibody, these happen early after an infection. Second there are the IgG antibodies, these are more likely to show up later, about 7 to 10 days after the symptoms start. IgG antibodies normally stay in your blood for a long time after an infection goes away. For coronavirus however, it’s not known how long these will stay in your blood.

‘We‘re not yet in a position to say that those who test positive in these antibody tests are immune for coronavirus.’ Matt Hancock mentioned in his daily briefing from Downing Street, which is important to keep in mind. There are multiple cases where people have been infected with COVID-19 twice.


‍How is it different from a PCR coronavirus test?

‍A PCR coronavirus swab test can only tell if a person currently has COVID-19. Not if they’ve had it in the past. This test can be done by taking a swab from your throat. The antibody test determines whether you’ve had coronavirus in the past, it won’t tell you if you’re currently infected. This test is done using a blood sample.

‍Why are the at-home antibody tests put on hold?

‍Public Health England (PHE) has approved the first antibody test, manufactured by Roche. As many of the finger prick antibody tests use the same technology in their labs as Roche, some providers wrongly claimed that their kits are PHE validated. But these home tests are not yet regarded as effective.

For this reason, all antibody testing services that use blood that's collected by a finger-prick have been temporarily stopped. This is until the home collection of this type of sample has been validated for use with these lab tests. Using the unvalidated sample types can lead to unreliable results. The MHRA is working closely with these labs and test manufacturers to resolve this. Everyone who has done one of these tests in the past should consider their results unreliable.

It’s also important to consider that antibodies are usually associated with immunity, which is not the case with the coronavirus antibody test. People who get back a positive result from the test might think they’re immune to the virus and that it’s ok for them to break social distancing measures. The antibody tests are said to be essential for people to go back to work, however there is no certainty that people won’t be able to get infected again, so at this point the tests can’t stop the lockdown procedures. Rightangled has opted out of offering antibody tests, you can hear more about why that is in the LBC radio interview with CEO, Abdullah Sabyah. To hear this interview please click here.

However, antibody tests administered by healthcare professionals have not been stopped by the MHRA, these tests use blood from the veins. These tests are currently still being used.

Latest Stories

View all

Navigating GLP-1 Medications: Ultimate Guide for the community

Navigating GLP-1 Medications: Ultimate Guide for the community

Dr Sohaib Imtiaz our Clinical Lead and Board certified Lifestyle Medicine Doctor went live with our community. Here are some of the questions we were asked.  As the landscape of weight management medications evolves, questions arise about specific drugs, their...

Read more

Shareholders' letter | Year end 2021 updates - Rightangled

Shareholders' letter | Year end 2021 updates

The copy of an email newsletter sent by CEO Abdullah Sabyah to Rightangled investors on Christmas day (25th of December 2021), the letter covers a full overview and updates from the year-end 2021 with a business outlook to the year 2022.

Read more

Rightangled: Changing the Way We Look at DNA

Rightangled: Changing the Way We Look at DNA

According to the World Health Organisation, cardiovascular diseases (CVD) are the leading cause of deaths worldwide. An estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. In the UK alone, 7 million people battle with CVDs every day. Rightangled...

Read more